Differential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis.
Keenan C, Albeituni S, Oak N, Stroh A, Tillman HS, Wang Y, Freeman BB 3rd, Alemán-Arteaga S, Meyer LK, Woods R, Verbist KC, Zhou Y, Cheng C, Nichols KE.
Keenan C, et al. Among authors: meyer lk.
Blood. 2024 Jun 6;143(23):2386-2400. doi: 10.1182/blood.2023021046.
Blood. 2024.
PMID: 38446698